Long-range massively parallel mate pair sequencing detects distinct mutations and similar patterns of structural mutability in two breast cancer cell lines

Cancer Genetics

Volumn 204, Issue 8, 2011, Pages 447-457

  Hampton, Oliver A ^a,b   Miller, Christopher A ^a,c   Koriabine, Maxim ^d   Li, Jian ^a   Den Hollander, Petra ^a,e   Carbone, Lucia ^d,f   Nefedov, Mikhail ^d   Ten Hallers, Boudewijn F H ^d   Lee, Adrian V ^a,g   De Jong, Pieter J ^d   Milosavljevic, Aleksandar ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BioNanomatrix Inc   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Copy number variation; Fosmid diTag; Gene fusion; Genomic instability; Massively parallel sequencing

Indexed keywords

DNA FRAGMENT; MESSENGER RNA; DNA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRUCTURE; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE FUSION; GENE INSERTION SEQUENCE; GENE LIBRARY; GENE MAPPING; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENOMIC INSTABILITY; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOLECULAR PATHOLOGY; MOLECULAR WEIGHT; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TRANSCRIPTION REGULATION; BREAST TUMOR; CHROMOSOME ABERRATION; CHROMOSOME MAP; DNA SEQUENCE; FEMALE; GENETICS; HUMAN GENOME; METHODOLOGY; MUTATION; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; DNA, NEOPLASM; FEMALE; GENOME, HUMAN; GENOMIC INSTABILITY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84856382664     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2011.07.009     Document Type: Article

References (57)

1. Bignell G.R., Santarius T., Pole J.C., et al. Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. Genome Res 2007, 17:1296-1303.
2. Kidd J.M., Cooper G.M., Donahue W.F., et al. Mapping and sequencing of structural variation from eight human genomes. Nature 2008, 453:56-64.
3. Tuzun E., Sharp A.J., Bailey J.A., et al. Fine-scale structural variation of the human genome. Nat Genet 2005, 37:727-732.
4. Volik S., Raphael B.J., Huang G., et al. Decoding the fine-scale structure of a breast cancer genome and transcriptome. Genome Res 2006, 16:394-404.
5. Volik S., Zhao S., Chin K., et al. End-sequence profiling: sequence-based analysis of aberrant genomes. Proc Natl Acad Sci U S A 2003, 100:7696-7701.
6. Bentley D.R., Balasubramanian S., Swerdlow H.P., et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 2008, 456:53-59.
7. Campbell P.J., Stephens P.J., Pleasance E.D., et al. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 2008, 40:722-729.
8. Korbel J.O., Urban A.E., Affourtit J.P., et al. Paired-end mapping reveals extensive structural variation in the human genome. Science 2007, 318:420-426.
9. Maher C.A., Palanisamy N., Brenner J.C., et al. Chimeric transcript discovery by paired-end transcriptome sequencing. Proc Natl Acad Sci U S A 2009, 106:12353-12358.
10. McKernan K.J., Peckham H.E., Costa G.L., et al. Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. Genome Res 2009, 19:1527-1541.
11. Pleasance E.D., Cheetham R.K., Stephens P.J., et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010, 463:191-196.
12. Stephens P.J., McBride D.J., Lin M.L., et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 2009, 462:1005-1010.
13. Berger M.F., Lawrence M.S., Demichelis F., et al. The genomic complexity of primary human prostate cancer. Nature 2011, 470:214-220.
14. Hillmer A.M., Yao F., Inaki K., et al. Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes. Genome Res 2011, 21:665-675.
15. Alkan C., Sajjadian S., Eichler E.E. Limitations of next-generation genome sequence assembly. Nat Methods 2011, 8:61-65.
16. Teague B., Waterman M.S., Goldstein S., et al. High-resolution human genome structure by single-molecule analysis. Proc Natl Acad Sci U S A 2010, 107:10848-10853.
17. Das S.K., Austin M.D., Akana M.C., et al. Single molecule linear analysis of DNA in nano-channel labeled with sequence specific fluorescent probes. Nucleic Acids Res 2010, 38:e177.
18. Gnerre S., Maccallum I., Przybylski D., et al. High-quality draft assemblies of mammalian genomes from massively parallel sequence data. Proc Natl Acad Sci U S A 2011, 108:1513-1518.
19. Fullwood M.J., Wei C.L., Liu E.T., et al. Next-generation DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses. Genome Res 2009, 19:521-532.
20. Ruan Y., Ooi H.S., Choo S.W., et al. Fusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs). Genome Res 2007, 17:828-838.
21. Chen J., Kim Y.C., Jung Y.C., et al. Scanning the human genome at kilobase resolution. Genome Res 2008, 18:751-762.
22. Raghavendra N.K., Rao D.N. Exogenous AdoMet and its analogue sinefungin differentially influence DNA cleavage by R.EcoP15I-usefulness in SAGE. Biochem Biophys Res Commun 2005, 334:803-811.
23. Korbel J.O., Abyzov A., Mu X.J., et al. PEMer: a computational framework with simulation-based error models for inferring genomic structural variants from massive paired-end sequencing data. Genome Biol 2009, 10:R23.
24. Chen K., Wallis J.W., McLellan M.D., et al. BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods 2009, 6:677-681.
25. Ye K., Schulz M.H., Long Q., et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 2009, 25:2865-2871.
26. Miller C.A., Hampton O., Coarfa C., et al. ReadDepth: a Parallel R package for detecting copy number alterations from short sequencing reads. PLoS One 2011, 6:e16327.
27. Bailey J.A., Yavor A.M., Massa H.F., et al. Segmental duplications: organization and impact within the current human genome project assembly. Genome Res 2001, 11:1005-1017.
28. Hampton O.A., Den Hollander P., Miller C.A., et al. A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. Genome Res 2009, 19:167-177.
29. Mootha V.K., Lepage P., Miller K., et al. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci U S A 2003, 100:605-610.
30. Inoue K., Lupski J.R. Molecular mechanisms for genomic disorders. Annu Rev Genomics Hum Genet 2002, 3:199-242.
31. Maher C.A., Kumar-Sinha C., Cao X., et al. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009, 458:97-101.
32. Inaki K., Hillmer A.M., Ukil L., et al. Transcriptional consequences of genomic structural aberrations in breast cancer. Genome Res 2011, 21:676-687.
33. Zhao Q., Caballero O.L., Levy S., et al. Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line. Proc Natl Acad Sci U S A 2009, 106:1886-1891.
34. Hu X., Stern H.M., Ge L., et al. Genetic alterations and oncogenic pathways associated with breast cancer subtypes. Mol Cancer Res 2009, 7:511-522.
35. Collins C., Volik S., Kowbel D., et al. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res 2001, 11:1034-1042.
36. Huang G., Krig S., Kowbel D., et al. ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction. Hum Mol Genet 2005, 14:3219-3225.
37. Bieche I., Olivi M., Nogues C., et al. Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays. Br J Cancer 2002, 86:580-586.
38. Liu Y., Tarsounas M., O'Regan P., et al. Role of RAD51C and XRCC3 in genetic recombination and DNA repair. J Biol Chem 2007, 282:1973-1979.
39. Miller K.A., Sawicka D., Barsky D., et al. Domain mapping of the Rad51 paralog protein complexes. Nucleic Acids Res 2004, 32:169-178.
40. Lewis A.G., Flanagan J., Marsh A., et al. Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer. Breast Cancer Res 2005, 7:R1005-R1016.
41. Yu X., Chini C.C., He M., et al. The BRCT domain is a phospho-protein binding domain. Science 2003, 302:639-642.
42. Cantor S.B., Bell D.W., Ganesan S., et al. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 2001, 105:149-160.
43. Kim H., Chen J., Yu X. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science 2007, 316:1202-1205.
44. Liu Z., Wu J., Yu X. CCDC98 targets BRCA1 to DNA damage sites. Nat Struct Mol Biol 2007, 14:716-720.
45. Akbari M.R., Ghadirian P., Robidoux A., et al. Germline RAP80 mutations and susceptibility to breast cancer. Breast Cancer Res Treat 2009, 113:377-381.
46. Novak D.J., Sabbaghian N., Maillet P., et al. Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases. Breast Cancer Res Treat 2009, 117:453-459.
47. Yu X. Characterize RAP80, a potential tumor suppressor gene 2009, University of Michigan - Ann Arbor, U.S. Army Medical Research and Materiel Command, p. 24.
48. Hicks J., Krasnitz A., Lakshmi B., et al. Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res 2006, 16:1465-1479.
49. Abeysinghe S.S., Chuzhanova N., Krawczak M., et al. Translocation and gross deletion breakpoints in human inherited disease and cancer I: nucleotide composition and recombination-associated motifs. Hum Mutat 2003, 22:229-244.
50. Bashir A., Liu Y.T., Raphael B.J., et al. Optimization of primer design for the detection of variable genomic lesions in cancer. Bioinformatics 2007, 23:2807-2815.
51. Bashir A, Lu Q, Carson D, et al. Optimizing PCR assays for DNA-based cancer diagnostics. J Comput Biol;17:369-381.
52. Krzywinski M., Schein J., Birol I., et al. Circos: an information aesthetic for comparative genomics. Genome Res 2009, 19:1639-1645.
53. Barlund M., Monni O., Weaver J.D., et al. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer. Genes Chromosomes Cancer 2002, 35:311-317.
54. Huang G.L., Zhang X.H., Guo G.L., et al. Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma. Oncol Rep 2009, 21:673-679.
55. Heinonen H., Nieminen A., Saarela M., et al. Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer. BMC Genomics 2008, 9:348.
56. Tamura K., Makino A., Hullin-Matsuda F., et al. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism. Cancer Res 2009, 69:8133-8140.
57. Liu L., Gong G., Liu Y., et al. Multi-species comparative mapping in silico using the COMPASS strategy. Bioinformatics 2004, 20:148-154.